
Akari Therapeutics PLC (AKTX)
NASDAQ
Quarter End | 9 2020 | 12 2020 | 3 2021 | 6 2021 | 9 2021 | 12 2021 | 3 2022 | 6 2022 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -248k | -6.92M | -5.55M | -4.33M | -1.46M | -5.9M | -5.24M | -5.82M |
税引前収入 | 1.44M | -6.82M | -5.84M | -4.35M | -1.45M | -5.79M | -5.18M | -5.68M |
純利益 | 1.44M | -6.82M | -5.84M | -4.35M | -1.45M | -5.79M | -5.18M | -5.68M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 869k | -6.92M | -5.56M | -4.34M | -1.47M | -5.9M | -5.25M | -5.83M |
EBITDA | -247k | -6.93M | -5.55M | -4.33M | -1.46M | -5.9M | -5.24M | -5.82M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 199k | 556k | 0 | 0 | 330k |
営業利益 | -27.25M | -37.79M | -26.5M | -16.78M | -17.45M | -17.24M | -25.4M | -19.73M |
税引前収入 | -26.22M | -37.93M | -23.5M | -16.85M | -17.08M | -17.42M | -19.48M | -13.43M |
純利益 | -26.22M | -29.24M | -19.95M | -16.85M | -17.08M | -17.42M | -17.01M | -12.24M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.022 | -0.019 | -0.013 | -0.011 | -0.008 | -0.004 | -0.002 | -0.001 |
EBIT | -27.25M | -37.79M | -23.8M | -16.78M | -17.45M | -17.24M | -25.4M | -19.73M |
EBITDA | -27.2M | -37.75M | -26.47M | -16.77M | -17.44M | -17.24M | -25.4M | -19.72M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約